Skip to main content
Equibles
SSII logo

SSII · SS Innovations International, Inc.

Track SSII — free

Use SSII with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about SSII

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$3.60 +0.00 (+0.00%)
Going-concern doubt — flagged Aug 13, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the unaudited interim condensed consolidated financial statements are issued.”
View the 10-Q filed Aug 13, 2026
Market Cap
$723.39M
Shares
200.39M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$3.60 Open$3.74 Day$3.57–3.81 52W close$3.29–9.98 Avg vol 30d65K Short int79K · 0.0% float · 1.0d Short vol17% Last earningsOct 28, 2025 DataAug 2024–Aug 2026 Filing10-Q · Aug 13

Up next

FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 13, 2026

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Excellent Quant / Vol Very High
Market backdrop VIX 14.9 · calm Equity put/call 0.52
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −23%
below
Price vs 50-day avg −2%
below
RSI (14) 44
neutral
MACD trend Negative
52-week position 5%
near low
Momentum
relative strength
Very Weak
1-month return +1%
trailing
6-month return −24%
trailing
YTD return −37%
this year
Relative strength −36%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $4 › 200d $5 — 200d above 50d
Institutional flow Distributing
-12% holders QoQ · +1 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.04% of float · ▼ -39.7% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
23 holders — mid 1-yr range
Squeeze score 29
low risk · 0–100
Fundamentals
Excellent
Revenue growth +106%
Y/Y
Gross margin 46%
expanding
EPS growth +45%
Y/Y
Free cash flow $-22.2M
Balance sheet $2.2M
net cash
Quant / Vol
risk profile
Very High
Volatility 95%
annualized · 1-yr
Max drawdown −67%
past year
ATR 6.9%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−23% Bearish
Price vs 50-day avg
−2% Neutral
RSI (14)
44 Neutral
MACD trend
Negative Bearish
52-week position
5% Bearish
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $4 › 200d $5 — 200d above 50d
Institutional flow Distributing
-12% holders QoQ · +1 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.04% of float · ▼ -39.7% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
23 holders — mid 1-yr range
Price context
position in its 52-week range
Range low $3 Now $4 · 5% Range high $10
vs 200-day avg -23% vs 50-day avg -2%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Cumulative surgeries 12,272 As of June 30, 2026 —
SSi Mantra cumulative installed base 224 As of June 30, 2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Medical Devices — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
SSII
SS Innovations International, Inc.
this stock
$723.39M -36.6% +105.7% — 0.0%
ABT
Abbott Laboratories
 $196.27B -8.7% +5.7% 31.6 1.3%
SYK
Stryker Corp
 $127.26B -3.3% +11.2% 34.4 2.2%
MDT
Medtronic plc
 $120.49B -2.0% +8.4% 25.2 1.4%
BSX
Boston Scientific Corp
 $73.14B -45.5% +12.5% 20.4 1.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
23
% held
0.8%
Net QoQ
-34.2K sh
Top holder
Hood River Capital Manage…
Held Float
View
Held by Funds
Fund positions
8
View
Short & Settlement
Short Interest Falling
Shares short
79.0K
Days to cover
1.0d
Change
-52.0K sh
View
Short Volume
Short vol %
17%
As of
Aug 19, 2026
Short Total
View
Fails to Deliver
FTD shares
1.0K
Value
$3.9K
As of
Jul 30, 2026
View
Off-Exchange
Off-exchange %
26.6%
Week of
Jul 13, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$42.5M
Net income (FY)
$-12.1M
EPS diluted
$-0.06
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 13, 2026
This year
25
View
Exempt Offerings
Offering
$18.6M
Filed
Mar 19, 2026
View
Earnings & Events
Earnings Calls
Last call
Nov 12, 2025
View

Performance

5D 20D 120D MTD YTD
SSII -2.4% +0.6% -24.2% -9.6% -36.6%
SPY -0.4% +2.9% +11.6% +3.0% +12.8%
vs SPY -2.0% -2.3% -35.8% -12.5% -49.4%
Key facts CIK 1676163 CUSIP 05453U203 13F (30d) 20 filings 20 filers Visit website

Report a Problem

Category
Description
Email (optional, for follow-up)